A carregar...
Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status
INTRODUCTION: Although cetuximab and panitumumab show an increased efficacy for patients with KRAS-NRAS-BRAF and PI3KCA wild-type metastatic colorectal cancer, primary resistance occurs in a relevant subset of molecularly enriched populations. PATIENTS AND METHODS: We evaluated the outcome of 68 pat...
Na minha lista:
Main Authors: | , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3972159/ https://ncbi.nlm.nih.gov/pubmed/24691006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0092147 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|